The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pericle, F.
Right arrow Articles by Segal, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pericle, F.
Right arrow Articles by Segal, D. M.
The Journal of Immunology, 1998, 160: 28-31.
Copyright © 1998 by The American Association of Immunologists


CUTTING EDGE

Cutting Edge: HIV-1 Infection Induces a Selective Reduction in STAT5 Protein Expression

Federica Pericle1,*, Ligia A. Pinto1,*, Stuart Hicks*, Robert A. Kirken{dagger}, Giuseppe Sconocchia*, Janice Rusnak{ddagger}, Matthew J. Dolan{ddagger}, Gene M. Shearer* and David M. Segal2,*

* Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD; {dagger} Intramural Research Support Program-Scientific Applications International Corporation, Frederick, Laboratory of Molecular Immunoregulation, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick, MD; {ddagger} HIV Unit, Wilford Hall Medical Center, Lackland Air Force Base, TX.

HIV-1 infection is accompanied by qualitative and quantitative defects in CD4+ T lymphocytes. Loss of immune function in HIV patients is usually associated with a profound dysregulation of cytokine production. To investigate whether cytokine signaling defects occur during HIV infection, PHA blasts from healthy human donors were infected with two strains of HIV-1 and screened for the expression of STAT proteins used in cytokine signaling. A selective decrease in STAT5B was seen 8 days after infection with the BZ167 dual-tropic HIV isolate, but not with the Ba-L, M-tropic strain. Based on these findings, purified T cells from HIV-infected patients in different stages of disease were also tested for STAT expression; decreases in STAT5A, STAT5B, and STAT1{alpha} were observed in all patients. The reduction in STATs seen in vivo and in vitro after HIV infection may contribute to the loss of T cell function in HIV disease.




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
A. E. Hogg, G. C. Bowick, N. K. Herzog, M. W. Cloyd, and J. J. Endsley
Induction of granulysin in CD8+ T cells by IL-21 and IL-15 is suppressed by human immunodeficiency virus-1
J. Leukoc. Biol., November 1, 2009; 86(5): 1191 - 1203.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
H. Lin, M. Nieda, J. F. Hutton, V. Rozenkov, and A. J. Nicol
Comparative gene expression analysis of NKT cell subpopulations
J. Leukoc. Biol., July 1, 2006; 80(1): 164 - 173.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Zhang, R. A. Kirken, L. Furian, S. Janczewska, X. Qu, W. W. Hancock, M. Wang, N. Tejpal, R. Kerman, B. D. Kahan, et al.
Allograft Rejection Requires STAT5a/b-Regulated Antiapoptotic Activity in T Cells but Not B Cells
J. Immunol., January 1, 2006; 176(1): 128 - 137.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Petrovas, Y. M. Mueller, I. D. Dimitriou, P. M. Bojczuk, K. C. Mounzer, J. Witek, J. D. Altman, and P. D. Katsikis
HIV-Specific CD8+ T Cells Exhibit Markedly Reduced Levels of Bcl-2 and Bcl-xL
J. Immunol., April 1, 2004; 172(7): 4444 - 4453.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. J. Warby, S. M. Crowe, and A. Jaworowski
Human Immunodeficiency Virus Type 1 Infection Inhibits Granulocyte-Macrophage Colony-Stimulating Factor-Induced Activation of STAT5A in Human Monocyte-Derived Macrophages
J. Virol., December 1, 2003; 77(23): 12630 - 12638.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. Magnani, E. Balestra, A. Fraternale, S. Aquaro, M. Paiardini, B. Cervasi, A. Casabianca, E. Garaci, and C.-F. Perno
Drug-loaded red blood cell-mediated clearance of HIV-1 macrophage reservoir by selective inhibition of STAT1 expression
J. Leukoc. Biol., November 1, 2003; 74(5): 764 - 771.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Behbod, Z. S. Nagy, S. M. Stepkowski, J. Karras, C. R. Johnson, W. D. Jarvis, and R. A. Kirken
Specific Inhibition of Stat5a/b Promotes Apoptosis of IL-2-Responsive Primary and Tumor-Derived Lymphoid Cells
J. Immunol., October 15, 2003; 171(8): 3919 - 3927.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Samten, P. Ghosh, A.-K. Yi, S. E. Weis, D. L. Lakey, R. Gonsky, U. Pendurthi, B. Wizel, Y. Zhang, M. Zhang, et al.
Reduced Expression of Nuclear Cyclic Adenosine 5'-Monophospate Response Element-Binding Proteins and IFN-{gamma} Promoter Function in Disease Due to an Intracellular Pathogen
J. Immunol., April 1, 2002; 168(7): 3520 - 3526.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Federico, Z. Percario, E. Olivetta, G. Fiorucci, C. Muratori, A. Micheli, G. Romeo, and E. Affabris
HIV-1 Nef activates STAT1 in human monocytes/macrophages through the release of soluble factors
Blood, November 1, 2001; 98(9): 2752 - 2761.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Behbod, R. A. Erwin-Cohen, M.-E. Wang, B. W. Trawick, X. Qu, R. Verani, B. D. Kahan, S. M. Stepkowski, and R. A. Kirken
Concomitant Inhibition of Janus Kinase 3 and Calcineurin-Dependent Signaling Pathways Synergistically Prolongs the Survival of Rat Heart Allografts
J. Immunol., March 15, 2001; 166(6): 3724 - 3732.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. B. Johnston, Y. Jiang, G. van Marle, M. B. Mayne, W. Ni, J. Holden, J. C. McArthur, and C. Power
Lentivirus Infection in the Brain Induces Matrix Metalloproteinase Expression: Role of Envelope Diversity
J. Virol., August 15, 2000; 74(16): 7211 - 7220.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
S. Salvadori, G. Martinelli, and K. Zier
Resection of Solid Tumors Reverses T Cell Defects and Restores Protective Immunity
J. Immunol., February 15, 2000; 164(4): 2214 - 2220.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Bovolenta, L. Camorali, A. L. Lorini, S. Ghezzi, E. Vicenzi, A. Lazzarin, and G. Poli
Constitutive Activation of STATs Upon In Vivo Human Immunodeficiency Virus Infection
Blood, December 15, 1999; 94(12): 4202 - 4209.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. D. Marshall, J. Chehimi, G. Gri, J. R. Kostman, L. J. Montaner, and G. Trinchieri
The Interleukin-12-Mediated Pathway of Immune Events Is Dysfunctional in Human Immunodeficiency Virus-Infected Individuals
Blood, August 1, 1999; 94(3): 1003 - 1011.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Yamashita, J. Xu, R. A. Erwin, W. L. Farrar, R. A. Kirken, and H. Rui
Differential Control of the Phosphorylation State of Proline-juxtaposed Serine Residues Ser725 of Stat5a and Ser730 of Stat5b in Prolactin-sensitive Cells
J. Biol. Chem., November 13, 1998; 273(46): 30218 - 30224.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. David, L. Bani, J.-L. Moreau, M.-P. Treilhou, T. Nakarai, M. Joussemet, J. Ritz, B. Dupont, G. Pialoux, and J. Theze
Regulatory dysfunction of the interleukin-2 receptor during HIV infection and the impact of triple combination therapy
PNAS, September 15, 1998; 95(19): 11348 - 11353.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Selliah and T. H. Finkel
Cutting Edge: JAK3 Activation and Rescue of T Cells from HIV gp120-Induced Unresponsiveness
J. Immunol., June 15, 1998; 160(12): 5697 - 5701.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.